288 related articles for article (PubMed ID: 21873236)
1. Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection.
Valkov E; Stamp A; Dimaio F; Baker D; Verstak B; Roversi P; Kellie S; Sweet MJ; Mansell A; Gay NJ; Martin JL; Kobe B
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14879-84. PubMed ID: 21873236
[TBL] [Abstract][Full Text] [Related]
2. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses.
Verstak B; Nagpal K; Bottomley SP; Golenbock DT; Hertzog PJ; Mansell A
J Biol Chem; 2009 Sep; 284(36):24192-203. PubMed ID: 19592497
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of the Toll/Interleukin-1 receptor (TIR) domains from the Brucella protein TcpB and host adaptor TIRAP reveal mechanisms of molecular mimicry.
Snyder GA; Deredge D; Waldhuber A; Fresquez T; Wilkins DZ; Smith PT; Durr S; Cirl C; Jiang J; Jennings W; Luchetti T; Snyder N; Sundberg EJ; Wintrode P; Miethke T; Xiao TS
J Biol Chem; 2014 Jan; 289(2):669-79. PubMed ID: 24275656
[TBL] [Abstract][Full Text] [Related]
5. Poxviral protein A46 antagonizes Toll-like receptor 4 signaling by targeting BB loop motifs in Toll-IL-1 receptor adaptor proteins to disrupt receptor:adaptor interactions.
Stack J; Bowie AG
J Biol Chem; 2012 Jun; 287(27):22672-82. PubMed ID: 22593572
[TBL] [Abstract][Full Text] [Related]
6. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88.
Dunne A; Ejdeback M; Ludidi PL; O'Neill LA; Gay NJ
J Biol Chem; 2003 Oct; 278(42):41443-51. PubMed ID: 12888566
[TBL] [Abstract][Full Text] [Related]
7. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
[TBL] [Abstract][Full Text] [Related]
8. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site.
Ulrichts P; Bovijn C; Lievens S; Beyaert R; Tavernier J; Peelman F
J Cell Sci; 2010 Jan; 123(Pt 2):256-65. PubMed ID: 20048342
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into TIR domain specificity of the bridging adaptor Mal in TLR4 signaling.
Lin Z; Lu J; Zhou W; Shen Y
PLoS One; 2012; 7(4):e34202. PubMed ID: 22485159
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling.
Ohnishi H; Tochio H; Kato Z; Orii KE; Li A; Kimura T; Hiroaki H; Kondo N; Shirakawa M
Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10260-5. PubMed ID: 19506249
[TBL] [Abstract][Full Text] [Related]
11. In silico approach to inhibition of signaling pathways of Toll-like receptors 2 and 4 by ST2L.
Basith S; Manavalan B; Govindaraj RG; Choi S
PLoS One; 2011; 6(8):e23989. PubMed ID: 21897866
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of the TLR adaptor MAL/TIRAP reveals an intact BB loop and supports MAL Cys91 glutathionylation for signaling.
Hughes MM; Lavrencic P; Coll RC; Ve T; Ryan DG; Williams NC; Menon D; Mansell A; Board PG; Mobli M; Kobe B; O'Neill LAJ
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6480-E6489. PubMed ID: 28739909
[TBL] [Abstract][Full Text] [Related]
13. Structure of the Toll/Interleukin-1 Receptor (TIR) Domain of the B-cell Adaptor That Links Phosphoinositide Metabolism with the Negative Regulation of the Toll-like Receptor (TLR) Signalosome.
Halabi S; Sekine E; Verstak B; Gay NJ; Moncrieffe MC
J Biol Chem; 2017 Jan; 292(2):652-660. PubMed ID: 27909057
[TBL] [Abstract][Full Text] [Related]
14. Differential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric tumourigenesis.
Kennedy CL; Najdovska M; Tye H; McLeod L; Yu L; Jarnicki A; Bhathal PS; Putoczki T; Ernst M; Jenkins BJ
Oncogene; 2014 May; 33(19):2540-6. PubMed ID: 23728346
[TBL] [Abstract][Full Text] [Related]
15. A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling.
Nagpal K; Plantinga TS; Wong J; Monks BG; Gay NJ; Netea MG; Fitzgerald KA; Golenbock DT
J Biol Chem; 2009 Sep; 284(38):25742-8. PubMed ID: 19509286
[TBL] [Abstract][Full Text] [Related]
16. Identification of binding sites for myeloid differentiation primary response gene 88 (MyD88) and Toll-like receptor 4 in MyD88 adapter-like (Mal).
Bovijn C; Desmet AS; Uyttendaele I; Van Acker T; Tavernier J; Peelman F
J Biol Chem; 2013 Apr; 288(17):12054-66. PubMed ID: 23460645
[TBL] [Abstract][Full Text] [Related]
17. Microbial recognition by Toll-like receptors.
Takeda K; Akira S
J Dermatol Sci; 2004 Apr; 34(2):73-82. PubMed ID: 15033189
[TBL] [Abstract][Full Text] [Related]
18. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
[TBL] [Abstract][Full Text] [Related]
19. o-Vanillin binds covalently to MAL/TIRAP Lys-210 but independently inhibits TLR2.
Rahaman MH; Thygesen SJ; Maxwell MJ; Kim H; Mudai P; Nanson JD; Jia X; Vajjhala PR; Hedger A; Vetter I; Haselhorst T; Robertson AAB; Dymock B; Ve T; Mobli M; Stacey KJ; Kobe B
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2313055. PubMed ID: 38416868
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of bacterial interference with TLR4 signaling by Brucella Toll/interleukin-1 receptor domain-containing protein TcpB.
Alaidarous M; Ve T; Casey LW; Valkov E; Ericsson DJ; Ullah MO; Schembri MA; Mansell A; Sweet MJ; Kobe B
J Biol Chem; 2014 Jan; 289(2):654-68. PubMed ID: 24265315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
